H.C. Wainwright analyst Joseph Pantginis downgraded Atreca to Neutral from Buy without a price target. The company announced a “drastic” corporate reorganization, revealing plans to restructure its operations with the aim of reducing costs and extending its operational timeline, the analyst tells investors in a research note. The firm’s prior valuation of Atreca was based solely on ATRC-101, which is now currently suspended or potentially discontinued outright in the future.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BCEL:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue